Friday, 12 April 2019

Johnson & Johnson wins U.S. FDA approval for bladder cancer drug

Johnson & Johnson's drug Balversa won U.S. approval as the first targeted therapy for advanced bladder cancer, the Food and Drug Administration announced on Friday.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)